Lawall Funding: How Much Did They Raise & Key Investors

How Much Did Lawall Raise?
Funding & Key Investors

Lawall, a prominent provider of prosthetics and orthotics services, has secured $2M in total capital, with a recent strategic investment of $2M. This significant financing underscores the company's established position in the healthcare sector and its ongoing commitment to enhancing patient mobility and quality of life through custom-designed solutions.

The company's funding trajectory indicates a mature stage of development, likely focused on scaling operations and expanding its service offerings across the USA. The recent strategic investment suggests a strong validation of Lawall's business model and its impact since its inception in 1977.

What is Lawall?

Lawall

Hospitals & Physicians Clinics

Medical Practice Management

Healthcare Services

Lawall is recognized as a leading provider of comprehensive prosthetics and orthotics services within the United States. The company specializes in crafting custom-designed solutions tailored to individuals of all age groups, aiming to significantly improve their mobility and overall quality of life. Lawall's expert team comprises dedicated orthotists and prosthetists who leverage cutting-edge technology to deliver highly personalized patient care. Their extensive service portfolio includes specialized pediatric care, a wide array of orthotic devices, and prosthetic limbs, ensuring that each patient receives support precisely matched to their unique requirements. Since its founding in 1977, Lawall has consistently demonstrated a commitment to excellence, making a substantial positive impact on the communities it serves.

How much funding has Lawall raised?

Lawall has raised a total of $2M across 1 funding round:

2020

Debt

$2M

Debt (2020): $2M with participation from PPP

What's next for Lawall?

With the recent major strategic investment, Lawall is poised for significant expansion and enhancement of its service delivery capabilities. This capital infusion is expected to fuel advancements in technology adoption, potentially leading to more sophisticated custom-designed prosthetic and orthotic solutions. Furthermore, the financing may support Lawall's strategic initiatives to broaden its geographical reach within the USA, making its specialized care accessible to a larger patient population. The company's long-standing history and focus on personalized patient outcomes position it favorably for continued growth and leadership in the prosthetics and orthotics market.

See full Lawall company page

See More Financial Insights